Large-scale randomized evidence: Large, simple trials and overviews of trials

https://doi.org/10.1016/0895-4356(94)00150-OGet rights and content

First page preview

First page preview
Click to open first page preview

References (26)

  • R Peto

    Why do we need systematic overview of randomized trials?

    Start Med

    (1987)
  • R Doll et al.

    The Causes of Cancer: quantitative estimates of avoidable risks of cancer in the United States today

    J Natl Cancer Inst USA

    (1981)
  • MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis

    Lancet

    (1991)
  • Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. ISIS-1

    Lancet

    (1986)
  • Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2

    Lancet

    (1988)
  • ISIS-3: A randomized trial of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction

    Lancet

    (1992)
  • Fourth International Study of Infarct Survival: protocol for a large, simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium

    Am J Cardiol

    (1991)
  • Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

    Lancet

    (1986)
  • GISSI-2: a factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction

    Lancet

    (1990)
  • Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

    Br Med J

    (1994)
  • Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients

    Lancet

    (1994)
  • Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women

    Lancet

    (1992)

    Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women

    Lancet

    (1992)
  • I Chalmers

    The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health care

    Ann NY Acad Sci

    (1993)
  • Cited by (0)

    This article is almost the same as the authors' chapter in Doing More Good Than Harm (Warren KS, Mosteller F, Eds.). Annals of the New York Academy of Sciences; 1993. Hence, no copyright in either is assented.

    View full text